Tenet Healthcare Exceeds Expectations in Q2 2026 with Strong Financial Results
Tenet Healthcare has reported a robust set of financial results for the second quarter of 2026, exceeding the company's own expectations and delivering strong growth across its hospital and ambulatory surgical (ASC) segments.
According to the company's Q2 2026 conference call transcript, Tenet's consolidated net operating revenues reached $5.6 billion in the quarter, with consolidated adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) totaling $1.304 billion - a 16.3% increase over prior year.
Adjusted diluted earnings per share increased by an impressive 52% to $6.12 compared to the same period in 2025, with adjusted EBITDA margin of 23.2% in Q2 2026. The company's hospital segment delivered particularly strong results, with second-quarter adjusted EBITDA reaching $762 million - a 22% growth over prior year.
The company's focus on higher acuity and value-based care has driven significant growth in same-store revenue across both segments, with USPI (the ambulatory surgical asset) generating $542 million in adjusted EBITDA - a 9% increase over second quarter 2025. The hospital segment also reported strong volume growth, with adjusted EBITDA margins reaching 22%, despite the expected impact of reductions in exchange enrollment.
Dr. Saum Sutaria, Chairman and Chief Executive Officer, noted that Tenet's continued outperformance is driven by a transformed portfolio of businesses, strategic focus on higher acuity specialty services, strong leadership at the local level, and effective management through the dynamic environment.
The company has increased its revenue, adjusted EBITDA, and cash flow guidance for 2026, reflecting its confidence in delivering continued growth and margin strength despite the challenges posed by payer mix shifts and insurance enrollment uncertainty. With a robust pipeline of partnerships interested in joining USPI this year, Tenet appears well-positioned to maintain its momentum in the healthcare sector.
"We are pleased with our second quarter results and believe they reflect the success of our strategy," said Dr. Sutaria. "Our focus on higher acuity care has driven growth across both segments, and we remain optimistic about the rest of the year."
Tenet's performance in Q2 2026 serves as a testament to the company's ability to navigate the complexities of the healthcare landscape and deliver strong financial results despite challenging market conditions.
